Effects of Metoclopramide and Hyoscine-N-Butyl Bromide on Motility of Duodenum in Male Rats and Quantum Computational Analysis

Abstract: Gastroenteritis with emesis is routinely treated with metoclopramide. An anticholinergic substance called hyoscine-N-butyl bromide (buscopan) prevents acetylcholine from acting on muscarinic receptors. This study aimed to ascertain how metoclopramide affected the duodenum motility caused by acetylcholine. Another objective is to examine the impact of metoclopramide alone and in combination with hyoscine-n-butyl bromide on duodenal motility. In this examination, the duodenum was separated by 1 cm, and 2 cm long strips of tissue were produced and fastened with both sides of surgical silk at both ends of the isolated organ bath. Tissue was then suspended from the device and isometric contractions were recorded. Acetylcholine was introduced to the duodenum (10-4 M). Metoclopramide (35 M), hyoscine-N-butyl bromide (15 M), and metoclopramide and hyoscine-N-butyl bromide (50 M) were added and incubated after 10 minutes. The duodenum displayed frequency, peak-to-peak, and amplitude responses to metoclopramide (35 M), hyoscine-N-butyl bromide (15 M), and metoclopramide and hyoscine-N-butyl (50 M) in this result. Based on quantum chemical calculations several chemical properties were studied and to determine the active center the Fukui function was considered.